Literature DB >> 30925620

Autoimmune Encephalitides and Rapidly Progressive Dementias.

Sarah F Wesley1, Damien Ferguson2.   

Abstract

Rapidly progressive dementia (RPD) or cognitive decline is a common presenting complaint in neurology. While primary dementia is often a concern, other forms of reversible dementia must be thoroughly considered. This article focuses on the growing field of autoimmune encephalitis (AE) as it pertains to the differential diagnostic considerations in a work-up for RPD. Understanding clues in the history and examination is the first step in identifying patients with a potential autoimmune cause for RPD. While testing for infectious and toxic-metabolic etiologies is commonly preformed, it is necessary to consider early ancillary testing for AE in appropriate cases of RPD. Autoantibody testing in the spinal fluid and serum, brain imaging, and electroencephalography all form the first line of investigations for AE. Treatment options and strategies depend on the AE subtype and a number of individual patient considerations. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2019        PMID: 30925620     DOI: 10.1055/s-0039-1678583

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  2 in total

1.  Rapidly progressive dementia-associated N-type voltage-gated calcium channel antibody encephalopathy.

Authors:  Smathorn Thakolwiboon; Amputch Karukote; Gyeongmo Sohn; Walter R Duarte-Celada; Parunyou Julayanont
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-09

Review 2.  Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature.

Authors:  Víctor Albarrán; Jesús Chamorro; Diana Isabel Rosero; Cristina Saavedra; Ainara Soria; Alfredo Carrato; Pablo Gajate
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.